BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30740412)

  • 1. CircPVT1: a bridge linking Hippo pathway and human cancers.
    He X; Su W; Zhou Y; Ge X; Zhou J; Ou C
    Ann Transl Med; 2018 Dec; 6(Suppl 2):S91. PubMed ID: 30740412
    [No Abstract]   [Full Text] [Related]  

  • 2. The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma.
    Zhu Y; Liu Y; Xiao B; Cai H; Liu M; Ma L; Yin H; Wang F
    Biol Open; 2019 Sep; 8(9):. PubMed ID: 31551242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC.
    Wang Z; Su M; Xiang B; Zhao K; Qin B
    Biochem Biophys Res Commun; 2019 May; 512(4):716-722. PubMed ID: 30922567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia.
    Hu J; Han Q; Gu Y; Ma J; McGrath M; Qiao F; Chen B; Song C; Ge Z
    Epigenomics; 2018 Jun; 10(6):723-732. PubMed ID: 29693417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed circPVT1 in oral squamous cell carcinoma promotes proliferation by serving as a miRNA sponge.
    He T; Li X; Xie D; Tian L
    Mol Med Rep; 2019 Oct; 20(4):3509-3518. PubMed ID: 31485648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1.
    Panda AC; Grammatikakis I; Kim KM; De S; Martindale JL; Munk R; Yang X; Abdelmohsen K; Gorospe M
    Nucleic Acids Res; 2017 Apr; 45(7):4021-4035. PubMed ID: 27928058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.
    Chen J; Li Y; Zheng Q; Bao C; He J; Chen B; Lyu D; Zheng B; Xu Y; Long Z; Zhou Y; Zhu H; Wang Y; He X; Shi Y; Huang S
    Cancer Lett; 2017 Mar; 388():208-219. PubMed ID: 27986464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance.
    Adhikary J; Chakraborty S; Dalal S; Basu S; Dey A; Ghosh A
    J Clin Pathol; 2019 Aug; 72(8):513-519. PubMed ID: 31154423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.
    Kun-Peng Z; Xiao-Long M; Chun-Lin Z
    Int J Biol Sci; 2018; 14(3):321-330. PubMed ID: 29559849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of Hippo signalling pathway in bladder cancer.
    Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
    J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Considerations in the Development of Hippo Pathway Inhibitors in Cancers.
    Kakiuchi-Kiyota S; Schutten MM; Zhong Y; Crawford JJ; Dey A
    Front Cell Dev Biol; 2019; 7():156. PubMed ID: 31475147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression.
    Qin S; Zhao Y; Lim G; Lin H; Zhang X; Zhang X
    Biomed Pharmacother; 2019 Mar; 111():244-250. PubMed ID: 30590312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Membrane and Vesicular Traffic in Regulation of the Hippo Pathway.
    Verghese S; Moberg K
    Front Cell Dev Biol; 2019; 7():384. PubMed ID: 32010696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo signaling in mammalian stem cells.
    Tremblay AM; Camargo FD
    Semin Cell Dev Biol; 2012 Sep; 23(7):818-26. PubMed ID: 23034192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.
    Zhou X; Wang Z; Huang W; Lei QY
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):10-5. PubMed ID: 25491506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities.
    Calses PC; Crawford JJ; Lill JR; Dey A
    Trends Cancer; 2019 May; 5(5):297-307. PubMed ID: 31174842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo Signaling in Cancer: Lessons From
    Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
    Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Hippo signaling pathway by ubiquitin modification.
    Kim Y; Jho EH
    BMB Rep; 2018 Mar; 51(3):143-150. PubMed ID: 29366444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.